SARS-CoV-2 membrane protein, envelope protein, and nucleocapsid protein (M, E, and N proteins)

The SARS-CoV-2 membrane (M), envelope (E), and nucleocapsid (N) proteins are the primary non-spike structural proteins essential for viral replication and pathogenesis. The M protein is the most abundant viral protein and serves as the central scaffold for assembly, coordinating interactions between the spike (S), E, and N proteins to form the viral envelope. The E protein is a small viroporin that forms pentameric ion channels, which are crucial for viral budding, release, and the triggering of host inflammatory responses, such as the cytokine storm. The N protein binds to the viral RNA genome to form the ribonucleoprotein complex, facilitating genome packaging and antagonizing host interferon responses to promote immune evasion. Because these proteins are highly conserved across SARS-CoV-2 variants, they are considered high-value targets for broad-spectrum antivirals. Small-molecule inhibitors like JNJ-9676 and CIM-834 target the M protein to disrupt assembly, while ion channel blockers such as hexamethylene amiloride and amantadine target the E protein to inhibit viral release.

Other names

SARS-CoV-2 structural proteinsMembrane protein (M)Envelope protein (E)Nucleocapsid protein (N)Matrix proteinE1 proteinsM proteinRibonucleoprotein

Inhibition of viral assembly and morphogenesis by stabilizing M protein dimers; blockade of E protein viroporin ion channel activity to prevent viral release and reduce inflammation; and disruption of N protein-RNA interactions to inhibit genome packaging and replication.